Aurobindo Pharma gains FDA approval for Mometasone Furoate Monohydrate Nasal Spray
In a major development within the pharmaceutical industry, Aurobindo Pharma Limited (Aurobindo) announced it has received final approval from the US Food & Drug Administration ... Read More
CuraTeQ Biologics achieves milestone in Omalizumab biosimilar development
CuraTeQ Biologics Private Limited, a fully integrated arm of Aurobindo Pharma Ltd, has announced significant progress in its biosimilar program, revealing that its Omalizumab biosimilar ... Read More
Aurobindo Pharma reports strong growth in Q3FY24 with record sales and EBITDA
Aurobindo Pharma Limited, a leading player in the pharmaceutical sector, has announced its consolidated financial results for the quarter ended December 31, 2023. The company ... Read More
Aurobindo Pharma gains FDA approval for Darunavir Tablets
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Darunavir Tablets, 600 mg and 800 ... Read More
FDA approves Ryzneuta by Evive Biotech for reducing febrile neutropenia in cancer patients
Evive Biotech, a global biopharmaceutical company and a subsidiary of Yifan Pharmaceutical Co. Ltd., along with New Jersey-based Acrotech Biopharma, a wholly-owned subsidiary of Aurobindo ... Read More
Aurobindo Pharma subsidiary earns FDA approval for Testosterone Cypionate Injection
In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited's dedicated subsidiary, Eugia Pharma Specialities Limited, has triumphantly gained the final nod from the ... Read More
Aurobindo Pharma’s subsidiary Eugia Pharma gets FDA approval for Icatibant Injection
In a pivotal move bolstering its footprint in the global pharmaceutical landscape, Aurobindo Pharma Limited's subsidiary, Eugia Pharma Specialities Limited, has achieved final authorization from ... Read More
Aurobindo Pharma gets tentative FDA approval for generic HIV treatment for children
Aurobindo Pharma Limited has achieved a significant milestone by securing the US Food and Drug Administration (FDA)'s tentative nod under the PEPFAR program for its ... Read More
Aurobindo Pharma subsidiary receives FDA approval for Plerixafor Injection
Eugia Pharma Specialities Limited, a fully-owned subsidiary of India-based Aurobindo Pharma Limited, has received final approval from the US Food and Drug Administration (FDA). This ... Read More
Aurobindo Pharma achieves promising results for breast cancer biosimilar in Phase 3 trial
Aurobindo Pharma has announced positive results from a Phase 3 clinical trial of its breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin), developed ... Read More